المؤلفون: Yiwen Bao, Jiaju Chen, Luting Duan, Fujue Wang, Han Lai, Zeming Mo, Weiliang Zhu

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: HER2 inhibitors, FAERS database, adverse drug events, hemorrhagic events, nervous system disorders, TDM-1, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1288362/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/f2a043436d5b4335b9071e75aa187524

المؤلفون: Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Gerardo Miceli Sopo, Giampiero Mazzaglia, Pierfranco Conte, Lorenzo Giovanni Mantovani

المصدر: Cancers; Volume 15; Issue 4; Pages: 1175

مصطلحات موضوعية: breast cancer, tucatinib, TDM-1, cost-effectiveness analysis, Italy

وصف الملف: application/pdf

Relation: https://dx.doi.org/10.3390/cancers15041175

الاتاحة: https://doi.org/10.3390/cancers15041175

المؤلفون: A. Falcón González, P. Estévez Garcia, A. Sánchez Gastaldo, I. Sánchez Simón, J. Salvador Boffil, M. Ruiz Borrego

المصدر: Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100314- (2021)

مصطلحات موضوعية: Trastuzumab emtansine, Tdm-1, Hemodialysis, Dialysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2468294221000137; https://doaj.org/toc/2468-2942

URL الوصول: https://doaj.org/article/0a002d5e6ca847738a8a7f4a2d50de59

المؤلفون: Yiwen Bao, Jiaju Chen, Luting Duan, Fujue Wang, Han Lai, Zeming Mo, Weiliang Zhu

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, HER2 inhibitors, FAERS database, adverse drug events, hemorrhagic events, nervous system disorders, TDM-1, Tucatinib

Relation: https://figshare.com/articles/dataset/DataSheet1_Comparing_the_difference_of_adverse_events_with_HER2_inhibitors_a_study_of_the_FDA_adverse_event_reporting_system_FAERS_pdf/25051697

الاتاحة: https://doi.org/10.3389/fphar.2024.1288362.s001
https://figshare.com/articles/dataset/DataSheet1_Comparing_the_difference_of_adverse_events_with_HER2_inhibitors_a_study_of_the_FDA_adverse_event_reporting_system_FAERS_pdf/25051697

المؤلفون: Linarić, Petra, Lepetić, Petra, Jezernik, Dejana, Kanceljak, Kristina, Tečić Vuger, Ana, Pavlović, Mirjana, Vazdar, Ljubica, Šeparović, Robert

المساهمون: Eduard Vrdoljak, Marijana Jazvić

مصطلحات موضوعية: Breast cancer, TDM-1

URL الوصول: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::85c6242617d20cb9b7ec29e3910a90cb
https://www.bib.irb.hr/1128321

المؤلفون: Mounsey, L.A., Deal, A.M., Keith, K.C., Benbow, J.M., Shachar, S.S., Zagar, T., Dees, E.C., Carey, L.A., Ewend, M.G., Anders, C.K.

المصدر: Clinical Breast Cancer, 18(1)

مصطلحات موضوعية: Trastuzumab, Lapatinib, TDM-1, Outcome, Brain metastases

Relation: https://cdr.lib.unc.edu/downloads/4f16cc10c?file=thumbnail; https://cdr.lib.unc.edu/downloads/4f16cc10c

الاتاحة: https://doi.org/10.17615/trts-kq36
https://cdr.lib.unc.edu/downloads/4f16cc10c?file=thumbnail
https://cdr.lib.unc.edu/downloads/4f16cc10c

المؤلفون: CAPPELLO, FRANCESCA

المساهمون: GIRON, MARIA CECILIA

مصطلحات موضوعية: carcinoma mammella, inibitori CDK4/6, everolimus, pertuzumab, TDM-1

Relation: Dipartimento di Scienze del Farmaco - DSF; FARMACIA Laurea Magistrale (D.M. 270/2004); 2020; http://hdl.handle.net/20.500.12608/2766

الاتاحة: https://hdl.handle.net/20.500.12608/2766

المؤلفون: Anthony Gonçalves, Jean-Philippe Spano, D. Azria

المساهمون: Epidémiologie, Systèmes d'Information, Modélisation, Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

المصدر: Critical Reviews in Oncology/Hematology
Critical Reviews in Oncology/Hematology, 2015, 94 (3), pp.270-278. ⟨10.1016/j.critrevonc.2015.01.007⟩
Critical Reviews in Oncology/Hematology, Elsevier, 2015, 94 (3), pp.270-278. ⟨10.1016/j.critrevonc.2015.01.007⟩

مصطلحات موضوعية: Oncology, Quality of life, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Satisfaction, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Targeted therapy, HER2-targeted therapy, Breast cancer, Trastuzumab, Internal medicine, medicine, Adjuvant therapy, Breast-conserving surgery, Humans, Chemotherapy, Molecular Targeted Therapy, Survival rate, Neoplasm Staging, Radiotherapy, business.industry, Early breast cancer, Hematology, medicine.disease, Combined Modality Therapy, 3. Good health, Radiation therapy, Patient Satisfaction, TDM-1, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0fc8d3486e5678be940ca28bbd79e2b
https://hal.umontpellier.fr/hal-02286307

المؤلفون: Spano, Jean-Philippe, Azria, David, Gonçalves, Anthony

المساهمون: Epidémiologie, Systèmes d'Information, Modélisation, Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: ISSN: 1040-8428 ; Critical Reviews in Oncology/Hematology ; https://hal.umontpellier.fr/hal-02286307 ; Critical Reviews in Oncology/Hematology, 2015, 94 (3), pp.270-278. ⟨10.1016/j.critrevonc.2015.01.007⟩.

مصطلحات موضوعية: Chemotherapy, Early breast cancer, HER2-targeted therapy, Quality of life, Radiotherapy, Satisfaction, TDM-1, Trastuzumab, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/25682223; hal-02286307; https://hal.umontpellier.fr/hal-02286307; PUBMED: 25682223

الاتاحة: https://hal.umontpellier.fr/hal-02286307
https://doi.org/10.1016/j.critrevonc.2015.01.007

المؤلفون: Pallag, Géza

المساهمون: Megyeri, Attila, Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet, DE--Általános Orvostudományi Kar, Pórszász, Róbert, Drimba, László, Kenézy Gyula Kórház és Rendelőintézet Aneszteziológiai és Intenzív Terápiás Osztály

مصطلحات موضوعية: TDM-1, Kadcyla, Her-2, emlőrák, trastuzumab emtansine, antitesthez konjugált toxin, daganat terápia, onkológia, DEENK Témalista::Orvostudomány::Farmakológia

وصف الملف: application/pdf

Relation: http://hdl.handle.net/2437/218528

الاتاحة: http://hdl.handle.net/2437/218528

المؤلفون: Antonazzo, I, Cortesi, P, Miceli Sopo, G, Mazzaglia, G, Conte, P, Mantovani, L, Antonazzo I. C., Cortesi P. A., Miceli Sopo G., Mazzaglia G., Conte P., Mantovani L. G.

مصطلحات الفهرس: breast cancer, cost-effectiveness analysi, Italy, TDM-1, tucatinib, info:eu-repo/semantics/article

URL: https://hdl.handle.net/10281/409479
info:eu-repo/semantics/altIdentifier/pmid/36831518
info:eu-repo/semantics/altIdentifier/wos/WOS:000938340300001
volume:15
issue:4
journal:CANCERS